Section
Imdelltra
The latest Imdelltra coverage from Bullquill: sourced, dated and explained.
1 POSTSUPDATED
IndexDate · Title · Reading time
No articles in this language here yet. Showing English.
-
Amgen lung cancer trial: Imdelltra cuts death risk by 58%
In 563 patients with extensive-stage small cell lung cancer, median survival was 21.1 months on the combination versus 12.7 months on Imfinzi alone. Serious side effects were about twice as common, at 20.9% versus 10.8%.
